AdvaMed Compiles List Of Tests That Should Be Exempt From FDA Review
This article was originally published in The Gray Sheet
Executive Summary
Device trade group AdvaMed has given FDA a list of 30 lower-risk diagnostic tests that it says should be exempt from pre-market review